Literature DB >> 11064474

Azoospermia in a patient with sickle cell disease treated with hydroxyurea.

G Garozzo, S Disca, C Fidone, P Bonomo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11064474

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

1.  Hydroxyurea therapy: a rare cause of reversible azoospermia.

Authors:  Junaid Masood; Azhar Hafeez; Andrew Hughes; Jayanta M Barua
Journal:  Int Urol Nephrol       Date:  2007-03-01       Impact factor: 2.370

Review 2.  Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care.

Authors:  Robert Sheppard Nickel; Jacqueline Y Maher; Michael H Hsieh; Meghan F Davis; Matthew M Hsieh; Lydia H Pecker
Journal:  J Clin Med       Date:  2022-04-21       Impact factor: 4.964

Review 3.  Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

Authors:  Sophie Lanzkron; John J Strouse; Renee Wilson; Mary Catherine Beach; Carlton Haywood; HaeSong Park; Catherine Witkop; Eric B Bass; Jodi B Segal
Journal:  Ann Intern Med       Date:  2008-05-05       Impact factor: 25.391

4.  Spermatogonial quantity in human prepubertal testicular tissue collected for fertility preservation prior to potentially sterilizing therapy.

Authors:  J-B Stukenborg; J P Alves-Lopes; M Kurek; H Albalushi; A Reda; V Keros; V Töhönen; R Bjarnason; P Romerius; M Sundin; U Norén Nyström; C Langenskiöld; H Vogt; L Henningsohn; R T Mitchell; O Söder; C Petersen; K Jahnukainen
Journal:  Hum Reprod       Date:  2018-09-01       Impact factor: 6.918

5.  Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility endpoints.

Authors:  Kea M Jones; Mohammad S Niaz; Cynthia M Brooks; Shannon I Roberson; Maria P Aguinaga; Edward R Hills; Valerie Montgomery Rice; Phillip Bourne; Donald Bruce; Anthony E Archibong
Journal:  Int J Environ Res Public Health       Date:  2009-03-16       Impact factor: 3.390

6.  Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease.

Authors:  Nm Wiles; J Howard
Journal:  Ther Clin Risk Manag       Date:  2009-09-24       Impact factor: 2.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.